scieee Science in your language
[en] (orig)

TO THE QUESTION OF CHOOSING THE RESEARCH OBJECT ON THE TOPIC OF NOOTROPIC DRUGS

Author: Ismailova M.K; Yunusova Kh.M
Publisher: Zenodo
DOI: 10.5281/zenodo.17326318
Source: https://zenodo.org/records/17326318/files/MPHAPP92.pdf
143
Volume 5, Issue 10: Special Issue
(EJAR)
ISSN: 2181-2020
MPHAPP
THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE “MODERN PHARMACEUTICS: ACTUAL
PROBLEMS AND PROSPECTS”
TASHKENT, OCTOBER 17, 2025
in-academy.uz
TO THE QUESTION OF CHOOSING THE RESEARCH OBJECT ON THE TOPIC
OF NOOTROPIC DRUGS
Ismailo a M.K.1
Yunuso a Kh.M.2
Tashken Pha maceu ical Ins i u e, Tashken ci y, Republic o Uzbekis an
e-mail: [email p o ec ed]
h ps://doi.o g/10.5281/zenodo.17326318
Rele ance: Noo opic d ugs occupy a key place in mode n neu ological and psychia ic
p ac ice, as hey help imp o e cogni i e unc ions, memo y eco e y, concen a ion, and
neu oplas ici y. Thei use is pa icula ly ele an in he ehabili a ion o pa ien s a e se ous
meningi is, auma ic b ain inju ies, s okes, and o he neu oin ec ions accompanied by cogni i e
impai men s. Acco ding o DRUG-audi da a o 2022–2024, he Republic o Uzbekis an has
wi nessed no only a s eady inc ease in sales o noo opic d ugs bu also an expansion o hei
he apeu ic applica ions. The sha e o noo opics in he psychoanalep ic d ug segmen consis en ly
exceeds 85% o he o al pha maceu ical ma ke in his ca ego y. The g ea es in e es is shown in
d ugs wi h he In e na ional Nonp op ie a y Names (INN) - Pi ace am, Ci icoline, Hopan enic acid,
and Meclo enoxa e - which demons a e high p esc ip ion a es, p o en e icacy, and a o able
clinical ou comes. Addi ionally, pha macoeconomic ac o s such as he a o dabili y o d ugs o
di e en popula ion g oups and hei inclusion in he apy s anda ds a e aken in o accoun .
Resea ch Objec i e: To de e mine he op imal objec o subsequen pha macological and
clinical s udies among noo opic d ugs, aking in o accoun DRUG-audi da a, INNs, clinical e icacy
indica o s, sa e y p o iles, and economic easibili y.
Ma e ials and Me hods: The s udy included a comp ehensi e analysis o DRUG-audi
s a is ical da a co e ing sales olumes, consump ion dynamics, and p ice segmen s o noo opic d ugs
o 2022–2024. Compa a i e analysis me hods we e addi ionally used o e alua e pha macological
p ope ies, sa e y p o iles, and equency o clinical use o d ugs wi h di e en INNs. To enhance
objec i i y, in o ma ion om in e na ional da abases and ecommenda ions om clinical p o ocols
on he use o noo opics in neu o ehabili a ion we e also u ilized.
Resul s: Acco ding o DRUG-audi da a, d ugs wi h he INNs Pi ace am and Ci icoline
consis en ly hold leading posi ions in e ms o sales olumes and p esc ip ion equency, accoun ing
o o e 40% o he en i e noo opic d ug ma ke . D ugs wi h he INNs Hopan enic acid and
Meclo enoxa e, al hough occupying a smalle ma ke sha e, demons a e a s eady posi i e end due
o hei ac i e use in he ehabili a ion o pa ien s a e neu ological diseases and in pedia ic p ac ice.
Conclusions: Based on a comp ehensi e analysis, d ugs wi h he INNs Ci icoline and
Hopan enic acid can be ecommended o u he pha macological and clinical s udies. They possess
p o en clinical e icacy, p onounced neu op o ec i e e ec s, accep able sa e y p o iles, and high
usage equency in eal-wo ld medical p ac ice. The use o DRUG-audi da a in combina ion wi h
INN analysis and pha macoeconomic ac o s makes i possible o jus i y he choice o he esea ch
objec no only om a clinical bu also om an economic and social pe spec i e. This is an impo an
aspec o de eloping a a ional pha maco he apy s a egy o cogni i e diso de s and ehabili a ion
o pa ien s wi h neu ological pa hology.